Developing robust, hydrogel-based, nanofiber-enabled encapsulation devices (NEEDs) for cell therapies

Biomaterials

Volumn 37, Issue , 2015, Pages 40-48

  An, Duo ^a   Ji, Yewei ^b   Chiu, Alan ^a   Lu, Yen Chun ^a   Song, Wei ^a   Zhai, Lei ^c   Qi, Ling ^b   Luo, Dan ^a   Ma, Minglin ^a  

^a Department of Biological and Environmental Engineering   (United States)

^b Department of Obstetrics Gynecology   (United States)

^c UNIVERSITY OF CENTRAL FLORIDA   (United States)

Author keywords

Cell encapsulation; Compartmentalization; Hydrogel devices; Nanofibers; Type 1 diabetes

Indexed keywords

BIOCOMPATIBILITY; CELLS; CROSSLINKING; CYTOLOGY; IMPLANTS (SURGICAL); MASS TRANSFER; NANOFIBERS; POROUS MATERIALS;

CELL ENCAPSULATIONS; COMPARTMENTALIZATION; ELECTROSPUN NANOFIBERS; MACROSCOPIC DIMENSIONS; MECHANICAL ROBUSTNESS; PRECURSOR SOLUTIONS; THERAPEUTIC APPLICATION; TYPE 1 DIABETES;

HYDROGELS;

NANOFIBER; HYDROGEL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL COMPARTMENTALIZATION; CELL ENCAPSULATION; CELL THERAPY; CONTROLLED STUDY; CROSS LINKING; GENERAL MEDICAL DEVICE; HYDROGEL; MALE; MOUSE; NANOENCAPSULATION; NANOFABRICATION; NANOFIBER ENABLED ENCAPSULATION DEVICE; NONHUMAN; PANCREAS ISLET; PRIORITY JOURNAL; RAT; WATER CONTENT; ANIMAL; BIOLOGICAL THERAPY; C57BL MOUSE; CHEMISTRY; DEVICES; HUMAN; MECHANICS; PANCREAS ISLET TRANSPLANTATION; SPRAGUE DAWLEY RAT; TUMOR CELL LINE; ULTRASTRUCTURE;

MUS; RATTUS;

ANIMALS; CELL LINE, TUMOR; CELL- AND TISSUE-BASED THERAPY; HUMANS; HYDROGEL; ISLETS OF LANGERHANS TRANSPLANTATION; MALE; MECHANICAL PHENOMENA; MICE, INBRED C57BL; NANOFIBERS; RATS, SPRAGUE-DAWLEY;

EID: 84922247797     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2014.10.032     Document Type: Article

References (59)

1. Dolgin E. Encapsulate this. Nat Med 2014, 20:9-11.
2. Calafiore R. Alginate microcapsules for pancreatic islet cell graft immunoprotection: struggle and progress towards the final cure for type 1 diabetes mellitus. Expert Opin Biol Ther 2003, 3:201-205.
3. Vaithilingam V., Tuch B.E. Islet transplantation and encapsulation: an update on recent developments. Rev Diabet Stud 2011, 8:51-67.
4. Zanin M.P., Pettingill L.N., Harvey A.R., Emerich D.F., Thanos C.G., Shepherd R.K. The development of encapsulated cell technologies as therapies for neurological and sensory diseases. JControl Release 2012, 160:3-13.
5. Read T.A., Sorensen D.R., Mahesparan R., Enger P.O., Timpl R., Olsen B.R., et al. Local endostatin treatment of gliomas administered by microencapsulated producer cells. Nat Biotechnol 2001, 19:29-34.
6. Hortelano G., AlHendy A., Ofosu F.A., Chang P.L. Delivery of human factor IX in mice by encapsulated recombinant myoblasts: a novel approach towards allogeneic gene therapy of hemophilia B. Blood 1996, 87:5095-5103.
7. Wilson J.T., Chaikof E.L. Challenges and emerging technologies in the immunoisolation of cells and tissues. Adv Drug Deliv Rev 2008, 60:124-145.
8. Orive G., De Castro M., Kong H.J., Hernandez R.M., Ponce S., Mooney D.J., et al. Bioactive cell-hydrogel microcapsules for cell-based drug delivery. JControl Release 2009, 135:203-210.
9. Orive G., Hernandez R.M., Gascon A.R., Calafiore R., Chang T.M.S., De Vos P., et al. Cell encapsulation: promise and progress. Nat Med 2003, 9:104-107.
10. Chang T.M.S. Therapeutic applications of polymeric artificial cells. Nat Rev Drug Discov 2005, 4:221-235.
11. Geller R.L., Loudovaris T., Neuenfeldt S., Johnson R.C., Brauker J.H. Use of an immunoisolation device for cell transplantation and tumor immunotherapy. Bioartificial organs: science, medicine, and technology 1997, 438-451. New York Acad Sciences, New York. A. Prokop, D. Hunkeler, A.D. Cherrington (Eds.).
12. Geller R.L., Loudovaris T., Neuenfeldt S., Johnson R.C., Brauker J.H. Use of an immunoisolation device for cell transplantation and tumor immunotherapy. Ann N Y Acad Sci 1997, 831:438-451.
13. Chick W.L., Like A.A., Lauris V. Beta cell-culture on synthetic capillaries - artificial endocrine pancreas. Science 1975, 187:847-849.
14. Lacy P.E., Hegre O.D., Gerasimidi-Vazeou A., Gentile F.T., Dionne K.E. Maintenance of normoglycemia in diabetic mice by subcutaneous xenografts of encapsulated islets. Science 1991, 254:1782-1784.
15. Weber L.M., Lopez C.G., Anseth K.S. Effects of PEG hydrogel crosslinking density on protein diffusion and encapsulated islet survival and function. JBiomed Mater Res A 2009, 90:720-729.
16. Slaughter B.V., Khurshid S.S., Fisher O.Z., Khademhosseini A., Peppas N.A. Hydrogels in regenerative medicine. Adv Mater 2009, 21:3307-3329.
17. Annabi N., Tamayol A., Uquillas J.A., Akbari M., Bertassoni L.E., Cha C., et al. 25th Anniversary article: rational design and applications of hydrogels in regenerative medicine. Adv Mater 2014, 26:85-124.
18. Lee K.Y., Mooney D.J. Hydrogels for tissue engineering. Chem Rev 2001, 101:1869-1879.
19. Khademhosseini A., Langer R. Microengineered hydrogels for tissue engineering. Biomaterials 2007, 28:5087-5092.
20. de Vos P. Cell encapsulation: ready for the next step. Adv Drug Deliv Rev 2014, 67-68:1-2.
21. Thiele J., Ma Y.J., Bruekers S.M.C., Ma S.H., Huck W.T.S. 25th Anniversary article: designer hydrogels for cell cultures: a materials selection guide. Adv Mater 2014, 26:125-148.
22. Omer A., Duvivier-Kali V.F., Trivedi N., Wilmot K., Bonner-Weir S., Weir G.C. Survival and maturation of microencapsulated porcine neonatal pancreatic cell clusters transplanted into immunocompetent diabetic mice. Diabetes 2003, 52:69-75.
23. Lim F., Sun A.M. Microencapsulated islets as bioartificial endocrine pancreas. Science 1980, 210:908-910.
24. de Vos P., Faas M.M., Strand B., Calafiore R. Alginate-based microcapsules for immunoisolation of pancreatic islets. Biomaterials 2006, 27:5603-5617.
25. Wang T., Lacik I., Brissova M., Anilkumar A.V., Prokop A., Hunkeler D., et al. An encapsulation system for the immunoisolation of pancreatic islets. Nat Biotechnol 1997, 15:358-362.
26. Soon-Shiong P., Heintz R.E., Merideth N., Yao Q.X., Yao Z., Zheng T., et al. Insulin independence in a type 1 diabetic patient after encapsulated islet transplantation. Lancet 1994, 343:950-951.
27. Elliott R.B., Escobar L., Tan P.L.J., Muzina M., Zwain S., Buchanan C. Live encapsulated porcine islets from a type 1 diabetic patient 9.5 yr after xenotransplantation. Xenotransplantation 2007, 14:157-161.
28. Jacobs-Tulleneers-Thevissen D., Chintinne M., Ling Z., Gillard P., Schoonjans L., Delvaux G., et al. Sustained function of alginate-encapsulated human islet cell implants in the peritoneal cavity of mice leading to a pilot study in a type 1 diabetic patient. Diabetologia 2013, 56:1605-1614. Beta Cell Therapy Consortium E-F.
29. De Vos P., De Haan B., Wolters G.H., Van Schilfgaarde R. Factors influencing the adequacy of microencapsulation of rat pancreatic islets. Transplantation 1996, 62:888-893.
30. Ma M., Chiu A., Sahay G., Doloff J.C., Dholakia N., Thakrar R., et al. Core-shell hydrogel microcapsules for improved islets encapsulation. Adv Healthc Mater 2013, 2:667-672.
31. Weir G.C. Islet encapsulation: advances and obstacles. Diabetologia 2013, 56:1458-1461.
32. Onoe H., Okitsu T., Itou A., Kato-Negishi M., Gojo R., Kiriya D., et al. Metre-long cell-laden microfibres exhibit tissue morphologies and functions. Nat Mater 2013, 12:584-590.
33. Dufrane D., Goebbels R.M., Gianello P. Alginate macroencapsulation of pig islets allows correction of streptozotocin-induced diabetes in primates up to 6 months without immunosuppression. Transplantation 2010, 90:1054-1062.
34. Calvert P. Hydrogels for soft machines. Adv Mater 2009, 21:743-756.
35. Sun J.Y., Zhao X., Illeperuma W.R., Chaudhuri O., Oh K.H., Mooney D.J., et al. Highly stretchable and tough hydrogels. Nature 2012, 489:133-136.
36. Peppas N.A., Huang Y., Torres-Lugo M., Ward J.H., Zhang J. Physicochemical foundations and structural design of hydrogels in medicine and biology. Annu Rev Biomed Eng 2000, 2:9-29.
37. Gong J.P., Katsuyama Y., Kurokawa T., Osada Y. Double-network hydrogels with extremely high mechanical strength. Adv Mater 2003, 15:1155.
38. Huang T., Xu H.G., Jiao K.X., Zhu L.P., Brown H.R., Wang H.L. Anovel hydrogel with high mechanical strength: a macromolecular microsphere composite hydrogel. Adv Mater 2007, 19:1622.
39. Li D., Xia Y.N. Electrospinning of nanofibers: reinventing the wheel?. Adv Mater 2004, 16:1151-1170.
40. Agarwal S., Wendorff J.H., Greiner A. Progress in the field of electrospinning for tissue engineering applications. Adv Mater 2009, 21:3343-3351.
41. Liu W.Y., Thomopoulos S., Xia Y.N. Electrospun nanofibers for regenerative medicine. Adv Healthc Mater 2012, 1:10-25.
42. Song W., An D., Kao D.I., Lu Y.C., Dai G., Chen S., et al. Nanofibrous microposts and microwells of controlled shapes and their hybridization with hydrogels for cell encapsulation. ACS Appl Mater Interfaces 2014, 6:7038-7044.
43. Stankus J.J., Soletti L., Fujimoto K., Hong Y., Vorp D.A., Wagner W.R. Fabrication of cell microintegrated blood vessel constructs through electrohydrodynamic atomization. Biomaterials 2007, 28:2738-2746.
44. Panseri S., Cunha C., Lowery J., Del Carro U., Taraballi F., Amadio S., et al. Electrospun micro- and nanofiber tubes for functional nervous regeneration in sciatic nerve transections. BMC Biotechnol 2008, 8:39.
45. Xu C.H., Inokuma M.S., Denham J., Golds K., Kundu P., Gold J.D., et al. Feeder-free growth of undifferentiated human embryonic stem cells. Nat Biotechnol 2001, 19:971-974.
46. Lacy P.E., Kostianovsky M. Method for the isolation of intact islets of Langerhans from the rat pancreas. Diabetes 1967, 16:35-39.
47. Ricordi C., Gray D.W., Hering B.J., Kaufman D.B., Warnock G.L., Kneteman N.M., et al. Islet isolation assessment in man and large animals. Acta Diabetol Lat 1990, 27:185-195.
48. Washburn E.W. The dynamics of capillary flow. Phys Rev 1921, 17:273-283.
49. Balguid A., Mol A., van Marion M.H., Bank R.A., Bouten C.V., Baaijens F.P. Tailoring fiber diameter in electrospun poly(epsilon-caprolactone) scaffolds for optimal cellular infiltration in cardiovascular tissue engineering. Tissue Eng Part A 2009, 15:437-444.
50. Andrejecsk J.W., Cui J., Chang W.G., Devalliere J., Pober J.S., Saltzman W.M. Paracrine exchanges of molecular signals between alginate-encapsulated pericytes and freely suspended endothelial cells within a 3D protein gel. Biomaterials 2013, 34:8899-8908.
51. King A., Sandler S., Andersson A. The effect of host factors and capsule composition on the cellular overgrowth on implanted alginate capsules. JBiomed Mater Res 2001, 57:374-383.
52. Scharp D.W., Marchetti P. Encapsulated islets for diabetes therapy: history, current progress, and critical issues requiring solution. Adv Drug Deliv Rev 2014, 67-68C:35-73.
53. Rutledge G.C., Lowery J.L., Pai C.L. Characterization by mercury porosimetry of nonwoven fiber media with deformation. JEng Fibers Fabrics 2009, 4:1-13.
54. Vacanti N.M., Cheng H., Hill P.S., Guerreiro J.D., Dang T.T., Ma M., et al. Localized delivery of dexamethasone from electrospun fibers reduces the foreign body response. Biomacromolecules 2012, 13:3031-3038.
55. Zhang L., Cao Z., Bai T., Carr L., Ella-Menye J.R., Irvin C., et al. Zwitterionic hydrogels implanted in mice resist the foreign-body reaction. Nat Biotechnol 2013, 31:553-556.
56. Khanna O., Moya M.L., Opara E.C., Brey E.M. Synthesis of multilayered alginate microcapsules for the sustained release of fibroblast growth factor-1. JBiomed Mater Res A 2010, 95:632-640.
57. Ma M., Liu W.F., Hill P.S., Bratlie K.M., Siegwart D.J., Chin J., et al. Development of cationic polymer coatings to regulate foreign-body responses. Adv Mater 2011, 23:H189-H194.
58. Kroon E., Martinson L.A., Kadoya K., Bang A.G., Kelly O.G., Eliazer S., et al. Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells invivo. Nat Biotechnol 2008, 26:443-452.
59. Rezania A., Bruin J.E., Riedel M.J., Mojibian M., Asadi A., Xu J., et al. Maturation of human embryonic stem cell-derived pancreatic progenitors into functional islets capable of treating pre-existing diabetes in mice. Diabetes 2012, 61:2016-2029.